{"status": "Ok", "redirect_url": "https://www.prnewswire.com//news-releases/ultragenyx-pharmaceutical-inc-notice-of-april-6-2026-application-deadline-for-class-action-lawsuit---contact-lewis-kahn-esq-at-kahn-swick--foti-llc-before-application-deadline-302727707.html", "message": "News view counter 632030 successfully enlarged"}